Impact Biomedical (IBO) Goodwill & Intangibles (2022 - 2026)

Impact Biomedical (IBO) has 5 years of Goodwill & Intangibles data on file, last reported at $22.6 million in Q1 2026.

• Quarterly Goodwill & Intangibles rose 26.51% year-over-year to $22.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.6 million (up 26.51% YoY) and the FY2025 annual result came in at $17.0 million, up 699.86% from the prior year.
• Goodwill & Intangibles improved to $22.6 million in Q1 2026, from $17.0 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $68.7 million in Q3 2023 to a low of -$2.8 million in Q4 2024.
• A 5-year average of $32.5 million and a median of $43.2 million in 2024 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles sank 106.44% — and 2025, when it soared 699.86%.
• Tracing IBO's Goodwill & Intangibles over 5 years: stood at $45.1 million in 2022, then decreased by 2.47% to $44.0 million in 2023, then slumped by 106.44% to -$2.8 million in 2024, then soared by 699.86% to $17.0 million in 2025, then surged by 32.9% to $22.6 million in 2026.
• The last three Goodwill & Intangibles figures came in at $22.6 million (Q1 2026), $17.0 million (Q4 2025), and $17.3 million (Q3 2025), per Business Quant data.